Moderna Therapeutics just started trading, after the biggest initial public offering in biotech history. The stock slid 5.7 percent to $21.65 in its trading ...
News
- Moderna is sliding in its Wall Street debut after the biggest IPO in biotech history (MRNA, TBIO)
- Myriad study shows breast cancer recurrence test can predict therapy responses
The studies were presented at the San Antonio Breast Cancer Symposium. A retrospective analysis of five prospective studies evaluated 3,746 ...
- Leaders in SA biotech, military medicine to meet in inaugural summit
Several of San Antonio's heavy hitters in bioscience plan to meet with their military counterparts in the Alamo City in an effort to develop deeper ...
- Puma Biotechnology Presents Results from the Hormone Receptor Positive Subgroup in Phase III ...
... Subgroup in Phase III ExteNET Trial of Neratinib for HER2-Amplified, Early Stage Breast Cancer at the 2018 San Antonio Breast Cancer Symposium.
- Spectrum Pharmaceuticals Announces Results from the RECOVER Phase 3 Study of ROLONTIS ...
... from the Phase 3 RECOVER clinical study was presented during the 2018 San Antonio Breast Cancer Symposium ® (SABCS). ... Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, ...